orelabrutinib

Modify Date: 2025-08-22 10:51:42

orelabrutinib Structure
orelabrutinib structure
Common Name orelabrutinib
CAS Number 1655504-04-3 Molecular Weight 427.50
Density N/A Boiling Point N/A
Molecular Formula C26H25N3O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of orelabrutinib


Orelabrutinib (ICP-022) is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor. Orelabrutinib has the potential for B-cell malignancies treatment[1].

 Names

Name Orelabrutinib

 orelabrutinib Biological Activity

Description Orelabrutinib (ICP-022) is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor. Orelabrutinib has the potential for B-cell malignancies treatment[1].
Related Catalog
References

[1]. Wei Xu, et al. Safety, Tolerability and Efficacy of Orelabrutinib, Once a Day, to Treat Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia. Blood (2019) 134 (Supplement_1): 4319.

 Chemical & Physical Properties

Molecular Formula C26H25N3O3
Molecular Weight 427.50
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.